Bolt Biotherapeutics (BOLT) Enterprise Value (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Enterprise Value of -$11.8 million for Q1 2026, up 57.07% sequentially from -$27.5 million in Q4 2025, and down 28.71% YoY from -$16.6 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Enterprise Value (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Enterprise Value for 7 years, with the latest figure at -$11.8 million in Q1 2026.
- Quarterly Enterprise Value fell 28.71% year-over-year to -$11.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.8 million (down 28.71% YoY) and the FY2025 annual result came in at -$27.5 million, down 244.29% from the prior year.
- Enterprise Value climbed to -$11.8 million in Q1 2026 per BOLT's latest filing, from -$27.5 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$8.0 million in Q4 2024 and troughed at -$190.9 million in Q1 2022.
- A 5-year average of -$83.3 million and a median of -$73.7 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value jumped 93.6% in 2023, then tumbled 244.29% in 2025.
- Over 5 years, Enterprise Value stood at -$168.9 million in 2022, then surged by 93.6% to -$10.8 million in 2023, then rose by 26.1% to -$8.0 million in 2024, then sank by 244.29% to -$27.5 million in 2025, then jumped by 57.07% to -$11.8 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$11.8 million, -$27.5 million, and -$39.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - | -22.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.84 Mn |
| Mar 31, 2026 | -11.81 Mn |
| Dec 31, 2025 | -27.51 Mn |
| Sep 30, 2025 | -39.58 Mn |
| Jun 30, 2025 | -10.39 Mn |
| Mar 31, 2025 | -9.18 Mn |
| Dec 31, 2024 | -7.99 Mn |
| Sep 30, 2024 | -53.80 Mn |
| Jun 30, 2024 | -73.70 Mn |
| Mar 31, 2024 | -91.35 Mn |
| Dec 31, 2023 | -10.81 Mn |
| Sep 30, 2023 | -119.72 Mn |
| Jun 30, 2023 | -125.87 Mn |
| Mar 31, 2023 | -126.38 Mn |
| Dec 31, 2022 | -168.89 Mn |
| Sep 30, 2022 | -171.13 Mn |
| Jun 30, 2022 | -176.34 Mn |
| Mar 31, 2022 | -190.90 Mn |
| Dec 31, 2021 | -186.22 Mn |
| Sep 30, 2021 | -212.89 Mn |